Actavis UK’s ‘Excessive’ Price Hikes Targeted In Latest Competition Inquiry

 
• By Ian Schofield
  
Symbol of law and justice
Actavis is alleged to have broken competition law by charging "excessive and unfair" prices
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Drug Pricing

More from Scrip